Welcome to our dedicated page for Dyadic Intl Del SEC filings (Ticker: DYAI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Scanning Dyadic International’s filings for C1 platform breakthroughs or new licensing deals can feel like navigating a lab notebook written for regulators, not investors. That’s why Stock Titan organizes every Dyadic International insider trading Form 4 transactions record, 10-K narrative and 8-K material events explained in one place, then deploys AI-powered summaries to turn biotech jargon into clear takeaways.
Need the Dyadic International quarterly earnings report 10-Q filing to spot R&D burn rates or royalty revenue? Our engine delivers real-time alerts the moment the document hits EDGAR and produces concise highlights � revenue by segment, cash runway, pipeline milestones. Curious about governance? Review the Dyadic International proxy statement executive compensation tables or track Dyadic International executive stock transactions Form 4 without sifting through multiple PDFs. Each line item is linked to an expert note so you understand how share grants align with clinical progress.
Whether you’re comparing batches per fermenter or projecting vaccine scalability, understanding Dyadic International SEC documents with AI cuts research time drastically. Explore Dyadic International annual report 10-K simplified sections on manufacturing risk, dive into Dyadic International earnings report filing analysis for margin trends, or watch Dyadic International Form 4 insider transactions real-time before market moves. From initial idea to informed decision, our comprehensive coverage keeps every disclosure � including those hidden in exhibits � instantly accessible and crystal clear.
Dyadic International, Inc. reported results for the quarter ended June 30, 2025, showing revenue growth and a smaller operating loss versus the prior year. Total revenue was $966,630 for the quarter (versus $385,896 a year earlier) and $1,360,202 for the six months (versus $720,513). Net loss for the quarter was $(1,793,774) compared with $(2,045,223) a year ago; six-month net loss was $(3,821,353) versus $(4,054,819). Basic and diluted loss per share was $(0.06) for the quarter and $(0.13) for six months.
Balance sheet and liquidity highlights show cash and cash equivalents of $2,140,899 and restricted cash of $1,833,531 related to the Gates Foundation grant. Total assets were $8.14 million and total liabilities $8.67 million, producing stockholders' equity of $(529,701). Convertible notes net carrying amounts were $1,070,971 (related party) and $3,930,170 (third party). Post-period the company closed an offering on August 1, 2025 that generated net proceeds of approximately $5.3 million; management states existing funds plus the offering are expected to cover at least 12 months, subject to assumptions stated in the filing.
Dyadic International, Inc. (Nasdaq: DYAI) received a Nasdaq Listing Qualifications notice on 17-Jul-2025 after its common stock failed to meet the $1.00 minimum bid price for the past 30 consecutive business days, violating Rule 5550(a)(2).
The notice does not immediately affect DYAI’s listing. The company has 180 calendar days—until 13-Jan-2026—to regain compliance by achieving a closing bid of at least $1.00 for 10 consecutive trading days. If the requirement is unmet, Dyadic may qualify for a second 180-day grace period, provided it satisfies all initial listing standards other than bid price and formally notifies Nasdaq of its remediation plan. Failure to cure could result in delisting, with the option to appeal.
Management “intends to actively monitor� share price and explore alternatives to resolve the deficiency. The filing also reminds investors that the company remains out of compliance with the $35 million Market Value of Listed Securities rule (Rule 5550(b)(2)); that separate deficiency must be remedied by 20-Dec-2025. Either unresolved deficiency can independently trigger delisting.
FAQ
What is the current stock price of Dyadic Intl Del (DYAI)?
What is the market cap of Dyadic Intl Del (DYAI)?
